Bayer AG

OTC: BAYRY · Real-Time Price · USD
7.54
0.01 (0.13%)
At close: Jun 06, 2025, 3:59 PM

Bayer Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.19B 5.91B 5.17B 4.56B
Short-Term Investments
1.9B 4.68B 4.98B 3.17B
Long-Term Investments
1.13B 3.45B -2.09B -563M
Other Long-Term Assets
3.53B 1.27B 6.09B 4.59B
Receivables
9.89B 9.35B 10.32B 10.05B
Inventory
13.4B 13.95B 13.6B 11.27B
Other Current Assets
2.9B 3.67B 3.65B 3.47B
Total Current Assets
34.44B 37.56B 37.76B 32.58B
Property-Plant & Equipment
13.46B 13.32B 13.67B 12.69B
Goodwill & Intangibles
52.13B 55.66B 63.83B 66.36B
Total Long-Term Assets
76.41B 86.25B 87.12B 87.66B
Total Assets
110.85B 116.26B 124.88B 120.24B
Account Payables
7.52B 7.46B 7.54B 6.79B
Deferred Revenue
n/a 2.13B 4.2B 14.31B
Short-Term Debt
4.9B 6.54B 7.58B 2.82B
Other Current Liabilities
14.79B 10.55B 14.24B 4.12B
Total Current Liabilities
28.95B 29.46B 35.08B 29.4B
Long-Term Debt
34.55B 37.23B 32.83B 35.55B
Other Long-Term Liabilities
13.15B 14.29B 15.75B 19.49B
Total Long-Term Liabilities
49.85B 53.72B 50.87B 57.67B
Total Liabilities
78.81B 83.18B 85.95B 87.07B
Total Debt
40.7B 44.79B 41.32B 39.53B
Common Stock
2.52B 2.52B 2.52B 2.52B
Retained Earnings
n/a 12.18B 17.23B 13.35B
Comprehensive Income
n/a -24M 764M -1.1B
Shareholders Equity
31.91B 32.93B 38.77B 33.02B
Total Investments
3.02B 8.13B 2.9B 2.61B